ABT

SELL

Abbott Laboratories

Healthcare · Rank #249 · Analyzed Jul 13, 2026

$93.93

Current Price

$62.85

Intrinsic Value

-33.1%

Upside/Downside

2.5/10

Score

2.5/5

Quality

Analysis Summary

Valuation Consensus0/3 methods agree

Quality Score2.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 33.1%

Fair Value Range

Low$10.66

Base (IV)$62.85

High$80.67

Entry Points

Conservative$7.46

Moderate$10.66

Aggressive$43.99

Quality & Moat Breakdown

Return on Equity12.3% → 0.5/1.0

Debt LevelD/E 65 → 0/1.0

Revenue QualityGrowth 3.0%, margin Δ+6.0% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins13.9% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.